GPCR Earnings Date: Nov 5, 2026 (Estimated) — Structure Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is GPCR's next earnings date?
Structure Therapeutics Inc. (GPCR) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.33 on revenue of $50.0M.
How did GPCR do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Structure Therapeutics Inc. posted EPS of -$0.49 versus the -$0.39 estimate, a miss of 28.9%. Revenue was $0. The stock's 1-day post-earnings move was +1.0%.
How much does GPCR stock move after earnings?
GPCR beat EPS estimates in 1 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.1% (up or down) in the day after earnings.
About Structure Therapeutics Inc.
Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1 receptor (GLP-1R). This G-protein-coupled receptor (GPCR) is a recognized and validated therapeutic target for managing both type-2 diabetes mellitus and obesity. Furthermore, Structure Therapeutics is developing other oral small molecule treatments that act on different GPCRs, addressing pulmonary and cardiovascular conditions. For example, ANPA-0073 is a biased agonist aimed at the apelin receptor, a GPCR linked to diseases like idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension. Another compound in their pipeline is LTSE-2578, an oral small molecule that acts as a lysophosphatidic acid 1 receptor antagonist, also being explored for the treatment of IPF. Established in 2016, the company was formerly known as ShouTi Inc. and is headquartered in South San Francisco, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.39 | -0.49 | -28.95% | $0 | ❌ Miss | +0.99% | +3.95% | -10.03% |
| 2026-05-07 | Q1 2026 | -0.33 | -0.35 | -6.06% | $0 | ❌ Miss | -0.13% | +1.76% | -3.52% |
| 2026-02-26 | Q4 2025 | -0.36 | -0.36 | +0.00% | $0 | ➖ Inline | -2.73% | -7.80% | -29.08% |
| 2025-11-06 | Q3 2025 | -0.36 | -0.37 | -2.78% | $0 | ❌ Miss | -1.88% | +4.57% | +109.08% |
| 2025-08-06 | Q2 2025 | -0.33 | -0.36 | -9.09% | $0 | ❌ Miss | -0.67% | +17.47% | +35.38% |
| 2025-02-27 | Q4 2024 | -0.17 | -0.22 | -29.41% | $0 | ❌ Miss | +4.08% | +3.11% | -13.37% |
| 2024-11-13 | Q3 2024 | -0.20 | -0.20 | +0.00% | $0 | ➖ Inline | +3.63% | -10.06% | -14.08% |
| 2024-03-08 | Q4 2023 | -0.21 | -0.16 | +23.81% | $0 | ✅ Beat | +2.36% | -2.30% | +23.33% |
Showing last 8 quarters.